West Pharmaceutical Services, Inc. (WST) — Fair Value Analysis
Base-case fair value (P50): $333.68 · Current price: $349.42 · Verdict: Fairly Valued
The Verdict on WST
Our latest Monte Carlo simulations indicate that West Pharmaceutical Services (WST) is currently Fairly Valued. The stock's current trading price of $349.42 is positioned near our median fair value estimate (P50) of $333.68. This analysis suggests a -4.5% gap, placing WST within a range we consider reasonable given its fundamental drivers and the probabilistic outcomes of thousands of forward-looking scenarios. The "Fairly Valued" verdict reflects that, while there isn't significant immediate upside to its median P50 target, it's not substantially overpriced either.
How WST stacks up against Healthcare
Within the Healthcare sector, WST exhibits an average quality tier, reflecting its operational and financial health relative to peers. This average standing informs our Monte Carlo model, influencing the distribution of potential outcomes for $349.42. Despite the slight negative -4.5% compared to our $333.68 estimate, the company's consistent performance within its sector supports the "Fairly Valued" assessment. An average quality tier implies a stable operational landscape, which our simulations factor into their long-term growth and margin assumptions, anchoring the $333.68 around $333.68.
What this means for investors
For investors considering WST at its current $349.42, the "Fairly Valued" verdict suggests a balanced risk-reward profile based on our simulations. While the -4.5% indicates that the stock is currently trading slightly above its median fair value of $333.68, this deviation is not significant enough to warrant an "Overvalued" rating. Those looking for substantial undervaluation might find better opportunities elsewhere, but WST's average quality in the Healthcare sector offers a degree of stability. To explore the full bear and bull case distribution and track WST's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is WST overvalued or undervalued right now?
Based on our Monte Carlo simulations, WST is currently considered Fairly Valued, trading at $349.42 which is slightly above its median fair value estimate (P50) of $333.68.
What is the bear case and bull case for WST?
The full Monte Carlo distribution, including specific bear-case (P10) and bull-case (P90) price targets, as well as the probability of achieving upside, is available with a free FairCurve account. We do not provide these specific dollar values publicly.
How does FairCurve calculate WST's fair value?
FairCurve calculates WST's fair value through a sophisticated Monte Carlo simulation, analyzing thousands of forward-looking scenarios to determine a probabilistic range of potential intrinsic values.
How can I track WST's fair value as it changes?
You can add WST to your free FairCurve watchlist to receive daily updates on its fair value. Our models instantly re-evaluate the stock when new earnings or significant fundamental data are released.